Distribution of α2-Adrenergic Receptors in the Living Human Brain Using [11C]yohimbine PET
Biomolecules · 15.05.2023 · 13 (5) · 843
DOI: 10.3390/biom13050843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 15.05.2023. Verfasst von Chloé Laurencin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université de Lyon, 69622 Lyon, France. Hauptthemen laut MEDLINE: Receptors, Adrenergic, alpha-2, Brain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Agency of Research.
Abstract (Originalsprache)
The neurofunctional basis of the noradrenergic (NA) system and its associated disorders is still very incomplete because in vivo imaging tools in humans have been missing up to now. Here, for the first time, we use [11C]yohimbine in a large sample of subjects (46 healthy volunteers, 23 females, 23 males; aged 20–50) to perform direct quantification of regional alpha 2 adrenergic receptors’ (α2-ARs) availability in the living human brain. The global map shows the highest [11C]yohimbine binding in the hippocampus, the occipital lobe, the cingulate gyrus, and the frontal lobe. Moderate binding was found in the parietal lobe, thalamus, parahippocampus, insula, and temporal lobe. Low levels of binding were found in the basal ganglia, the amygdala, the cerebellum, and the raphe nucleus. Parcellation of the brain into anatomical subregions revealed important variations in [11C]yohimbine binding within most structures. Strong heterogeneity was found in the occipital lobe, the frontal lobe, and the basal ganglia, with substantial gender effects. Mapping the distribution of α2-ARs in the living human brain may prove useful not only for understanding the role of the NA system in many brain functions, but also for understanding neurodegenerative diseases in which altered NA transmission with specific loss of α2-ARs is suspected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université de Lyon, 69622 Lyon, France.
- Université Claude Bernard Lyon 1, 69100 Villeurbanne, France.
- INSERM U1028, Lyon Neuroscience Research Center (CRNL), 69000 Lyon, France.
- CNRS UMR5292, Lyon Neuroscience Research Center (CRNL), 69000 Lyon, France.
- Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Hospices Civils de Lyon, 69677 Bron, France.
- CERMEP-Imagerie du Vivant, 69500 Bron, France.
ORCID-Profile: Nicolas Costes, Philippe Boulinguez, Bénédicte Ballanger
Förderung
- French National Agency of Research
Zitieren
APA
Laurencin, C., Lancelot, S., Merida, I., Costes, N., Redouté, J., Le Bars, D., Boulinguez, P., & Ballanger, B. (2023). Distribution of α2-Adrenergic Receptors in the Living Human Brain Using [11C]yohimbine PET. Biomolecules, 13(5), 843. https://doi.org/10.3390/biom13050843
Vancouver
Laurencin C, Lancelot S, Merida I, Costes N, Redouté J, Le Bars D, et al. Distribution of α2-Adrenergic Receptors in the Living Human Brain Using [11C]yohimbine PET. Biomolecules. 2023;13(5):843. doi:10.3390/biom13050843
BibTeX
@article{Laurencin2023,
author = {Laurencin, Chloé and Lancelot, Sophie and Merida, Inès and Costes, Nicolas and Redouté, Jérôme and Le Bars, Didier and Boulinguez, Philippe and Ballanger, Bénédicte},
title = {Distribution of α2-Adrenergic Receptors in the Living Human Brain Using [11C]yohimbine PET},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {5},
pages = {843},
doi = {10.3390/biom13050843}
}
EUVIMED